Data Collection in Lutetium Treated Prostate Cancer: Recording of Progression and Tumor Characteristics (LUTRAC)

Erasmus University

Status: Enrolling

Conditions: Prostate Cancer Metastatic

Treatments: Diagnostic Test: Blood draw for ctDNA and circulating tumor cell collection.

Study type: Observational

Funder types: Other

Identifiers

NCT06260410

10512

NL84672.078.23 (Other Identifier)

Details and patient eligibility

About

This prospective study aims to collect data and blood biomarkers from patients undergoing Lu-PSMA therapy at the Erasmus MC. In doing so, it will provide real-world efficacy and safety data on the drug, gather dosimetry data and explore putative biomarkers to identify patients who most benefit from Lu-PSMA treatment.

Enrollment: 150 estimated patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participants should be at least 18 years old.
• Participants should be able to understand the written information and be able to provide informed consent.
• Participants are planned to start treatment with Lu-PSMA as a part of regular clinical care.

Exclusion criteria

None applicable